Quantal components of end-plate potentials in the myasthenic syndrome.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials; D000328:Adult; D000368:Aged; D001984:Bronchial Neoplasms / Q000503:physiopathology*; D002277:Carcinoma / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004566:Electrodes; D004576:Electromyography; D005260:Female; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007366:Intercostal Muscles / Q000503:physiopathology; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials; D008839:Microelectrodes; D008875:Middle Aged; D009046:Motor Neurons / Q000503:physiopathology; D009119:Muscle Contraction; D009135:Muscular Diseases / Q000503:physiopathology*; D009157:Myasthenia Gravis / Q000503:physiopathology; D009210:Myofibrils / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology*; D009435:Synaptic Transmission
D002800:Cholinesterase Inhibitors; D006146:Guanidines; D008274:Magnesium; D000109:Acetylcholine